Cargando…
Design, synthesis, and biological evaluation of 3-vinyl-quinoxalin-2(1H)-one derivatives as novel antitumor inhibitors of FGFR1
FGFR1 is well known as a molecular target in anticancer drug design. TKI258 plays an important role in RTK inhibitors. Utilizing TKI258 as a lead compound that contains a quinazolinone nucleus, we synthesized four series of 3-vinyl-quinoxalin-2(1H)-one derivatives, a total of 27 compounds. We furthe...
Autores principales: | Liu, Zhiguo, Yu, Shufang, Chen, Di, Shen, Guoliang, Wang, Yu, Hou, Leping, Lin, Dan, Zhang, Jinsan, Ye, Faqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861610/ https://www.ncbi.nlm.nih.gov/pubmed/27217720 http://dx.doi.org/10.2147/DDDT.S88587 |
Ejemplares similares
-
Metal-Free Direct C–H Functionalization of Quinoxalin-2(1H)-Ones to Produce 3-Vinylated Quinoxalin-2(1H)-Ones in the Presence of Alkenes
por: Ding, Rongcai, et al.
Publicado: (2021) -
Design, synthesis and biological evaluation of 4-bromo-N-(3,5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer
por: Xie, Zixin, et al.
Publicado: (2018) -
Synthesis and Evaluation of New Quinoxaline Derivatives of Dehydroabietic Acid as Potential Antitumor Agents
por: Gu, Wen, et al.
Publicado: (2017) -
Synthesis, Characterization and Biological Evaluation of Some Quinoxaline Derivatives: A Promising and Potent New Class of Antitumor and Antimicrobial Agents
por: Al-Marhabi, Aisha R., et al.
Publicado: (2015) -
Synthesis and hypoglycemic activity of quinoxaline derivatives
por: Jia, Weidong, et al.
Publicado: (2023)